Granulomatous rosacea: a rare atypical variant
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20254127Keywords:
Chronic inflammatory dermatosis, Granulomatous rosacea, Granulomatous inflammationAbstract
Rosacea is a chronic inflammatory dermatosis mainly affecting the cheeks, nose, chin, and forehead. It is characterized by recurrent episodes of flushing, persistent erythema, phymatous changes, papules, pustules, and telangiectasia. Granulomatous rosacea (GR) is an uncommon variant of rosacea characterized by persistent erythema and papules usually seen in middle age women. Histopathology of GR shows granulomas in upper dermis and has a delayed therapeutic response compared to other types of rosacea. We report an atypical case of GR in a 19-year-old male. A 19-year-old male who presented with reddish dry raised lesions around mouth and nose of 3 months duration. On clinical examination diffuse shiny infiltrated plaques with ill-defined margins were seen over perioral region extending to nasolabial folds, lower forehead including glabellar region. Differential diagnosis of Granulomatous rosacea, Seborrheic dermatitis, Follicular mucinosis, Plaque sarcoidosis was considered. Histopathology showed normal epidermis, interstitial granulomatous infiltrate composed of epithelioid histiocytes, langhans giant cells, lymphocytes suggestive of GR. Patient was treated with oral minocycline 65 mg/day, broad spectrum sunscreen lotion, topical clindamycin gel daily night along with topical ivermectin once weekly resulting in marked clinical improvement after 8 weeks. Classical presentation of GR shows yellowish brown, red papules over cheeks, periorificial regions healing with scar formation. The present case had atypical clinical features presenting with infiltrated and well marginated plaques over multiple facial regions which was confirmed by histopathology and responded satisfactorily to the treatment.
Metrics
References
Almutairi RS, Al-Sabah HY. Facial Granulomatous Rosacea: A Case Report. Cureus. 2023;15(9):e45391. DOI: https://doi.org/10.7759/cureus.45391
Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol. 1991; 25(6):1038-43. DOI: https://doi.org/10.1016/0190-9622(91)70304-K
Lee GL, Zirwas MJ. Granulomatous rosacea and periorificial dermatitis: controversies and review of management and treat ment. Dermatol Clin. 2015;33(3):447-55. DOI: https://doi.org/10.1016/j.det.2015.03.009
Baglieri F, Scuderi G. Treatment of recalcitrant granulomatous rosacea with ALA-PDT: Report of a case. Indian J Dermatol Venereol Leprol. 2011;77:536 DOI: https://doi.org/10.4103/0378-6323.82420
Steinhoff M, Rosacea BJ. Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael AJ, Orringer JS. Fitzpatrick’s Dermatology in General Medicine. 9th ed. New York: McGraw‑Hill Education; 2019: 1419‑1447.
Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282-9. DOI: https://doi.org/10.1111/bjd.16481
Sarkar R, Podder I, Jagadeesan S. Rosacea in skin of color: A comprehensive review. Indian J Dermatol Venereol Leprol. 2020;86(6):611-21. DOI: https://doi.org/10.4103/ijdvl.IJDVL_769_19
Zuuren EJ, Linden MMD, Schaller M, Tan J. Rosacea. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R, Creamer D, eds. Rook’s Textbook of Dermatology. 10th ed. Oxford: Wiley-Blackwell; 2023: 89.2-89.7.
Sanchez JL, Berlingeri-Ramos AC, Due~no DV. Granulomatous rosacea. Am J Dermatopathol. 2008;30(1):6-9. DOI: https://doi.org/10.1097/DAD.0b013e31815bc191
Brady M, Wang V, Kartono F, Sikorski L. Granulomatous rosacea treated with tapinarof. JAAD Case Rep. 2025;64:113-6. DOI: https://doi.org/10.1016/j.jdcr.2025.06.038